← Leaderboards
Bert H O'Neil
University Of North Carolina Chapel Hill
$705,246
Attributed
$705,246
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $144.9K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$705,246 · 3
By mechanism
K23$683,525 · 1
M01$21,721 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert Zygmunt Orlowski$7,581,271
- Joel E Tepper$763,100
- Edward L. Chaney$6,667,107
- Dale A Ramsden$16,926,520
- Eric C. Frey$18,016,002
Others in their field
Top investigators on “Biopsy”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,871,847
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ralph Parchment · Leidos Biomedical Research, Inc.$43,674,966
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Peter Scott Heeger · Case Western Reserve University$37,822,090
Research focus
BiopsyClinical ResearchClinical TrialsGrantResearch PersonnelResponseResourcesCell LineAffectColostomy ProcedureBasic ScienceAntibodiesAnimal ModelCell SurvivalCancer TherapyColorectalClinically SignificantClinical EffectBortezomibClimactericCancer TypeApoptoticCollaborationsCessation Of Life
Grant awards (9)
Radiation-induced signaling and treatment resistance$136,705
K23 · FY2010 · CA · contact PI
Radiation-induced signaling and treatment resistance$136,705
K23 · FY2009 · CA · contact PI
Radiation-induced signaling and treatment resistance$136,705
K23 · FY2008 · CA · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF AZD6244 IN ADVANCED OR METASTATIC HEPATOCELL$536
M01 · FY2008 · RR · contact PI
Radiation-induced signaling and treatment resistance$136,705
K23 · FY2007 · CA · contact PI
Radiation-induced signaling and treatment resistance$136,705
K23 · FY2006 · CA · contact PI
ROLE OF INTESTINAL UGT'S ON IRINOTECAN DISPOSITION$8,177
M01 · FY2006 · RR · contact PI
ROLE OF INTESTINAL UGT'S ON IRINOTECAN DISPOSITION$11,310
M01 · FY2005 · RR
Role of Intestinal UGT's on Irinotecan Disposition$1,698
M01 · FY2004 · RR